Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

21

Number of overlapping holdings

70.0%

% of PJP's 30 holdings also in XPH

52.5%

% of XPH's 40 holdings also in PJP

Overlap by Weight
Sector Drift (PJP minus XPH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in PJP
Weight
in XPH
Overlap
ELI LILLY & CO 5.3% 4.3% 4.3%
JOHNSON & JOHNSON 5.3% 4.1% 4.1%
TARSUS PHARMACEUTICALS, INC. 3.7% 4.2% 3.7%
PFIZER INC 4.7% 3.7% 3.7%
MERCK & CO. INC. 4.8% 3.6% 3.6%

Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to XPH
ABBOTT LABORATORIES 5.4%
GILEAD SCIENCES INC 5.3%
AMGEN INC 5.0%
ABBVIE INC 4.8%
BIOGEN IDEC INC 2.5%
UNITED THERAPEUTICS CORP 2.4%
REGENERON PHARMACEUTICALS 2.4%
TRAVERE THERAPEUTICS, INC. 2.2%
GERON CORP 1.6%
BIOSANTE PHARMACEUTICALS INC 1.6%
PJP Underweight Relative to XPH
ROYALTY PHARMA PLC CLASS A -4.2%
ZOETIS INC -3.9%
AXSOME THERAPEUTICS, INC. -3.7%
ELANCO ANIMAL HEALTH, INC. -3.5%
ORGANON & CO. -3.2%
ARVINAS, INC. -2.8%
EDGEWISE THERAPEUTICS, INC. -2.1%
HARROW INC -1.9%
CORCEPT THERAPEUTICS INC -1.7%
VIATRIS, INC. -1.5%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY